StockNews.AI
EMBC
StockNews.AI
120 days

embecta to Report Fiscal Second Quarter 2025 Financial Results

1. Embecta Corp. will discuss Q2 2025 financial results on May 9, 2025. 2. The conference call includes an operational update and a Q&A session. 3. Embecta has a 100-year legacy in diabetes care and insulin delivery.

+2.84%Current Return
VS
+2.57%S&P 500
$10.9104/21 05:06 PM EDTEvent Start

$11.2204/22 11:47 PM EDTLatest Updated
3m saved
Insight
Article

FAQ

Why Bullish?

Upcoming earnings call may indicate strong performance and investor confidence, similar to previous quarters.

How important is it?

Earnings calls are pivotal for stock movement; positive signals can attract investments.

Why Short Term?

Investor sentiment and stock performance typically react quickly to earnings announcements.

Related Companies

April 21, 2025 17:00 ET  | Source: Embecta Corp. PARSIPPANY, N.J., April 21, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal second quarter 2025 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Friday, May 9, 2025. Those who would like to participate may access the live webcast here, or access the teleconference here. The live webcast can also be accessed via the company’s website at investors.embecta.com. A webcast replay of the call will be available beginning at 11:00 a.m. ET on May 9, 2025, via the embecta investor relations website and archived on the website for one year. About embecta embecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram. Contacts:     Media   Investors  Christian Glazar Pravesh KhandelwalSr. Director, Corporate CommunicationsVP, Head of Investor Relations908-821-6922 551-264-6547 Contact Media Relations   Contact IR  

Related News